Michael J. Fox Foundation Awards $2 Million To Fund A Clinical Trial Of Ketamine To Treat People With Parkinson’s Disease & Depression

The Michael J. Fox Foundation for Parkinson’s Research awarded $2 million to fund a clinical trial of ketamine to treat people with Parkinson’s disease and depression. The funding was awarded to researchers at Yale University.

Sophie E. Holmes, Ph.D., assistant professor of psychiatry and neurology, and Gerard Sanacora, M.D., Ph.D., George D. and Esther S. Gross Professor of Psychiatry, were named as co-principal investigators of the study. Three others affiliated with the university will join the effort, which is part of a new research program that combines the neurology and psychology departments.

For the . . .